ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 231 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $3,602,612 | +12.8% | 343,433 | +41.2% | 0.01% | +20.0% |
Q3 2023 | $3,195,096 | +112324.2% | 243,158 | +7.8% | 0.01% | – |
Q2 2023 | $2,842 | -99.9% | 225,582 | +22.3% | 0.00% | -100.0% |
Q1 2023 | $2,406,785 | -20.3% | 184,428 | +7.8% | 0.00% | -33.3% |
Q4 2022 | $3,018,557 | +108.5% | 171,120 | +80.0% | 0.01% | +100.0% |
Q3 2022 | $1,448,000 | +58.4% | 95,061 | +54.2% | 0.00% | +200.0% |
Q2 2022 | $914,000 | -22.6% | 61,640 | +17.6% | 0.00% | 0.0% |
Q1 2022 | $1,181,000 | +56.6% | 52,425 | +28.3% | 0.00% | 0.0% |
Q4 2021 | $754,000 | -78.5% | 40,874 | -84.4% | 0.00% | -66.7% |
Q3 2021 | $3,502,000 | -30.0% | 261,897 | -3.1% | 0.00% | -25.0% |
Q2 2021 | $5,002,000 | +208.0% | 270,237 | +149.8% | 0.00% | +100.0% |
Q1 2021 | $1,624,000 | -3.2% | 108,181 | -36.7% | 0.00% | 0.0% |
Q4 2019 | $1,678,000 | +206.8% | 170,982 | +344.9% | 0.00% | – |
Q3 2018 | $547,000 | +21.6% | 38,428 | +2.5% | 0.00% | – |
Q2 2018 | $450,000 | -92.0% | 37,477 | -91.7% | 0.00% | -100.0% |
Q1 2018 | $5,592,000 | -14.1% | 452,847 | +1.2% | 0.01% | 0.0% |
Q4 2017 | $6,512,000 | +22.6% | 447,560 | +19.9% | 0.01% | 0.0% |
Q3 2017 | $5,311,000 | +11.0% | 373,256 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $4,785,000 | -41.2% | 373,256 | -41.9% | 0.01% | -37.5% |
Q1 2017 | $8,142,000 | +4.2% | 642,097 | -16.1% | 0.01% | +14.3% |
Q4 2016 | $7,815,000 | +66.1% | 765,428 | +110.0% | 0.01% | +40.0% |
Q3 2016 | $4,706,000 | +3261.4% | 364,530 | +3193.0% | 0.01% | – |
Q2 2016 | $140,000 | -99.1% | 11,070 | -99.0% | 0.00% | -100.0% |
Q1 2016 | $14,950,000 | +118.9% | 1,131,724 | +154.9% | 0.02% | +112.5% |
Q4 2015 | $6,829,000 | +80.9% | 444,006 | +57.7% | 0.01% | +60.0% |
Q3 2014 | $3,776,000 | -13.8% | 281,475 | +3.1% | 0.01% | 0.0% |
Q2 2014 | $4,380,000 | -13.0% | 272,920 | -2.3% | 0.01% | -16.7% |
Q1 2014 | $5,037,000 | -62.3% | 279,345 | -67.7% | 0.01% | -64.7% |
Q4 2013 | $13,350,000 | +1.9% | 863,510 | -2.0% | 0.02% | 0.0% |
Q3 2013 | $13,101,000 | +15.7% | 881,055 | +0.7% | 0.02% | +6.2% |
Q2 2013 | $11,320,000 | – | 874,830 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |